{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:51:41Z","timestamp":1786117901244,"version":"build-2736575974"},"reference-count":30,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Microbiol Spectr"],"published-print":{"date-parts":[[2026,8,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The Fujifilm SILVAMP TB LAM II (FujiLAM II) assay is a lateral flow assay that detects TB from urine specimens. This updated version of the assay has been redesigned to address inter-lot variability issues of the original FujiLAM assay. We evaluated the diagnostic accuracy and inter-lot variability of the FujiLAM II assay on biobanked urine specimens collected from inpatients and outpatients living with HIV in two prospective studies conducted at hospitals in Cameroon. Diagnostic performance was evaluated against microbiological reference standards and compared to the Determine TB LAM Ag (AlereLAM) test and smear microscopy. From January to March 2025, urine specimens from 798 people with HIV were tested and analyzed, including 128 (16%) with microbiologically confirmed TB. Against a microbiological reference standard including two sputum liquid cultures and sputum, urine, and blood Xpert Ultra, the sensitivity of the FujiLAM II was 49% (58\/119, 95% CI 40%\u201358%) as compared to 35% (42\/119, 95% CI 27%\u201344%) on the AlereLAM, and the specificity of FujiLAM II was 96% (621\/650, 95% CI 94%\u201397%) as compared to 92% (601\/650, 95% CI 90%\u201394%) on the AlereLAM. Among a subset of 161 participants with any TB result positive, positivity across four manufacturing lots ranged from 37% (60\/161, 95% CI 30%\u201345%) to 42% (67\/161, 95% CI 34%\u201349%), with no significant difference across lots (Cochran\u2019s\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      = 4.2,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.2). These results suggest the FujiLAM II assay has the potential to improve TB diagnosis in some populations, as compared to the only currently available LAM test.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>IMPORTANCE<\/jats:title>\n                    <jats:p>Many people with TB are never diagnosed with and treated for the disease. While sputum-based tests for TB based on molecular diagnostics are highly sensitive, there are many barriers to access due to the high cost and infrastructure requirements of these tests. Accurate, point-of-care tests that can be conducted in peripheral settings without equipment and on non-sputum specimens have the potential to greatly increase access to TB testing and close this gap in care. The Fujifilm SILVAMP TB LAM II test is a new urine-based lateral flow test for TB. Our results show that this test is more sensitive to detect TB in people living with HIV than the only currently recommended urine point-of-care TB test and that the test has consistent performance across lots.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/spectrum.00620-26","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T01:19:26Z","timestamp":1782868766000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Diagnostic accuracy and inter-lot precision of the FujiLAM II point-of-care assay to detect tuberculosis in stored urine specimens from people living with HIV"],"prefix":"10.1128","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-5911-7702","authenticated-orcid":true,"given":"Nestor","family":"Biatu","sequence":"first","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-6311","authenticated-orcid":true,"given":"Cyrille","family":"Mbuli","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7253-638X","authenticated-orcid":true,"given":"Comfort","family":"Vuchas","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nsamenang","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadege Bonkar","family":"Chifu","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asonganyi","family":"Etiendem","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3099-730X","authenticated-orcid":true,"given":"Diana Kolieghu","family":"Tcheumeni","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7171-8014","authenticated-orcid":true,"given":"Angela","family":"Neh","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6112-4223","authenticated-orcid":true,"given":"Ngha","family":"Ndze Mbuh","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Kontogianni","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03svjbs84","id-type":"ROR","asserted-by":"publisher"}],"name":"Liverpool School of Tropical Medicine","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6441-2213","authenticated-orcid":true,"given":"Rachel","family":"Owen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03svjbs84","id-type":"ROR","asserted-by":"publisher"}],"name":"Liverpool School of Tropical Medicine","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8784-2635","authenticated-orcid":true,"given":"Ndi","family":"Norah Nyah","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/025fpk195","id-type":"ROR","asserted-by":"publisher"}],"name":"Cameroon Baptist Convention Health Service","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luan Nguyen","family":"Quang Vo","sequence":"additional","affiliation":[{"name":"Friends for International TB Relief","place":["Hanoi, Vietnam"]},{"id":[{"id":"https:\/\/ror.org\/056d84691","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Global Public Health, Karolinska Institute","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Codlin","sequence":"additional","affiliation":[{"name":"Friends for International TB Relief","place":["Hanoi, Vietnam"]},{"id":[{"id":"https:\/\/ror.org\/056d84691","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Global Public Health, Karolinska Institute","place":["Stockholm, Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Creswell","sequence":"additional","affiliation":[{"name":"Stop TB Partnership","place":["Geneva, Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1036-9376","authenticated-orcid":true,"given":"Melissa","family":"Sander","sequence":"additional","affiliation":[{"name":"Center for Health Promotion and Research","place":["Bamenda, Cameroon"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-124X","authenticated-orcid":true,"given":"Ana Isabel","family":"Cubas Atienzar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03svjbs84","id-type":"ROR","asserted-by":"publisher"}],"name":"Liverpool School of Tropical Medicine","place":["Liverpool, United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_5_2_2","unstructured":"World Health Organization. 2025. Global tuberculosis report 2025. Available from: https:\/\/iris.who.int\/handle\/10665\/383364. Retrieved 17 Jan 2026."},{"key":"e_1_3_5_3_2","unstructured":"World Health Organization. 2025. WHO operational handbook on tuberculosis. module 3: diagnosis. Geneva. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240110991. Retrieved 25 Aug 2025."},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(24)00178-5"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00025711"},{"key":"e_1_3_5_6_2","unstructured":"World Health Organization. 2019. Web Annex E. evidence to decision tables. in: lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV: policy update. Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/31f8f39c-2ece-4a38-a46f-60c724a0a95d\/content. Retrieved 10 Feb 2026."},{"key":"e_1_3_5_7_2","unstructured":"World Health Organization. 2015. The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the Diagnosis and screening of active tuberculosis in people living with HIV. policy guidance. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241509633. Retrieved 18 Jan 2026."},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.757133"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00463-6"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0303846"},{"key":"e_1_3_5_11_2","unstructured":"World Health Organisation. 2024. TSS-23 rapid diagnostic tests to detect mycobacterial lipoarabinomannan (LAM) antigen in urine technical specifications series for submission to WHO prequalification-diagnostic assessment. Available from: https:\/\/www.who.int\/publications\/b\/70818"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h5527"},{"key":"e_1_3_5_13_2","unstructured":"World Health Organization. 2024. Target product profiles for tuberculosis diagnosis and detection of drug resistance Geveva. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240097698. Retrieved 18 Jan 2026."},{"key":"e_1_3_5_14_2","unstructured":"Cepheid. 2023. Xpert MTB\/RIF ultra instructions for use. Available from: https:\/\/infomine.cepheid.com\/sites\/default\/files\/2024-01\/302-5776"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00332-13"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039966"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0432-2"},{"key":"e_1_3_5_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0258(19980430)17:8<891::aid-sim780>3.0.co;2-b"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-015-0034-x"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.11613\/BM.2012.031"},{"key":"e_1_3_5_21_2","unstructured":"World Health Organization. 2019. Lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis of active tuberculosis in people living with HIV. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789241550604"},{"key":"e_1_3_5_22_2","unstructured":"World Health Organization. 2024. WHO consolidated guidelines on tuberculosis. module 3: diagnosis \u2013 rapid diagnostics for tuberculosis detection third edition. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240107984. Retrieved 18 Jan 2026."},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.12688\/gatesopenres.13112.2"},{"key":"e_1_3_5_24_2","unstructured":"Stop TB Partnership Global Drug Facility. 2025. GDF diagnostics medical devices &amp; other health products catalog. Available from: https:\/\/www.stoptb.org\/sites\/default\/files\/documents\/GDF_Diagnostics_and_MD_Catalog.pdf"},{"key":"e_1_3_5_25_2","unstructured":"The Global Fund. 2025. List of TB diagnostic test kits and equipment classified according to the global fund quality assurance policy. Available from: https:\/\/www.theglobalfund.org\/media\/0dyh31gs\/psm_productsdiagnosticstb_list_en.pdf. Retrieved 31 Jan 2026."},{"key":"e_1_3_5_26_2","unstructured":"Global Health Innovative Technology (GHIT) Fund. 2025. Total investment of approx. USD 11.6 Million in TB and NTD R&D Projects with Partners Including FUJIFILM Stop TB Partnership and the Ohio State University. Available from: https:\/\/www.ghitfund.org\/newsroom\/press\/detail\/530\/en. Retrieved 31 Jan 2026."},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtldopen.24.0449"},{"key":"e_1_3_5_28_2","volume-title":"Evaluation of qualitative, binary output examination performanceCLSI guideline EP12","author":"(CLSI) C and LSI","year":"2023","unstructured":"(CLSI) C and LSI. 2023. Evaluation of qualitative, binary output examination performanceCLSI guideline EP12. 3rd ed. Clinical and Laboratory Standards Institute, USA.","edition":"3"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30001-5"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz530"},{"key":"e_1_3_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(19)30684-X"}],"container-title":["Microbiology Spectrum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00620-26","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/spectrum.00620-26","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T14:41:54Z","timestamp":1786027314000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/spectrum.00620-26"}},"subtitle":[],"editor":[{"given":"Sophia B.","family":"Georghiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,4]]}},"alternative-id":["10.1128\/spectrum.00620-26"],"URL":"https:\/\/doi.org\/10.1128\/spectrum.00620-26","relation":{},"ISSN":["2165-0497"],"issn-type":[{"value":"2165-0497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"2026-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00620-26"}}